In his annual Convocation address to the UMass Chan Medical School community on Thursday, Sept. 16, Chancellor Michael F. Collins expressed optimism for the Medical School’s ambitious future and touted the enormous momentum moving the school forward.

Findings from a new study led by UMass Chan Medical School researchers are the basis for a safety communication issued by the U.S. Food and Drug Administration Aug. 11 regarding serial use of at-home antigen tests for COVID-19.

A new paper from the lab of Lawrence Stern, PhD, indicates that some of the antigens on the virus that causes COVID-19 are common across all the human coronaviruses, such as those that cause the common cold, and that one particular peptide in the virus spike protein is among the most common antigens that promote an immune response worldwide.

BRIDGE Innovation and Business Development at UMass Chan Medical School has awarded $2.2 million to seven faculty-led biomedical research projects.

Carly Herbert, an MD/PhD student at UMass Chan Medical School, is a student investigator and the first or second author named on six publications on rapid COVID-19 tests.

David M. Harlan, MD, has been appointed as the new director of the JDRF Center of Excellence in New England. A renowned basic and clinical investigator, Dr. Harlan focuses on beta cell biology and the anti-beta cell immune response.

Infectious disease specialist Richard T. Ellison III, MD, provides updates on the SARS-CoV-2 virus.

Chancellor Michael F. Collins announced that the University’s Board of Trustees has approved the appointment of three of faculty members to endowed chairs. They join more than 60 named chairs at UMass Chan.

Graduating UMass Chan Medical School students from paths historically underrepresented in medicine and science were ceremonially presented Kente and multicultural stoles on Friday, June 3, to wear at the 49th Commencement.

In an article written for The Conversation, Nate Hafer, PhD, and Apurv Soni, MD, PhD'21, explain the data regarding accuracy of rapid COVID tests, based on their extensive reseach as part of the RADx team.